Phases of the serological response in Pseudomonas aeruginosa infections
- PMID: 3125715
Phases of the serological response in Pseudomonas aeruginosa infections
Abstract
Sixty-four infections due to Pseudomonas aeruginosa in patients of a respiratory intensive care unit were studied. The length of serologically latent period following the appearance of P. aeruginosa decreased with the growing severity of the infection, however, the longest latent period occurred in lethal cases. As the phase of development of peak anti-LPS antibody titres was constant in each group, in fatal infections the serological response developed too late when sepsis had already started. The duration of the persistence of peak titres was also stable. In consequence of a close negative correlation between these two latter parameters, the period from the onset of antibody increase till the beginning of decrease was especially constant, independent of the severity of infection, the duration of the antigenic stimulus and the intensity of the serological response. The rate of decrease was an another stable value. All these refer to an endogenous, time-dependent regulation which, despite existing clinical symptoms and the presence of P. aeruginosa, starts anti-LPS antibody level to decline. Pseudomonas carrier state in convalescence was observed in cases with prolonged persistence of peak titre and with a lower rate of titre decrease.
Similar articles
-
Immunoserology of Pseudomonas aeruginosa infections in man. II. effect of natural and immune anti-LPS antibodies on pseudomonas colonization and infection.Acta Microbiol Hung. 1984;31(2):101-8. Acta Microbiol Hung. 1984. PMID: 6431739
-
Immunoserology of Pseudomonas aeruginosa infections in man. I. Four types of interaction between host and bacterium.Acta Microbiol Hung. 1984;31(2):91-100. Acta Microbiol Hung. 1984. PMID: 6431740
-
Immunoserology of Pseudomonas aeruginosa infections in man. III. Site of infection, duration of the presence of Pseudomonas aeruginosa and antibody response.Acta Microbiol Hung. 1984;31(2):109-16. Acta Microbiol Hung. 1984. PMID: 6464657
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.Biopolymers. 2003;71(2):141-68. doi: 10.1002/bip.10395. Biopolymers. 2003. PMID: 12767116 Review.
Cited by
-
Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview.Front Oncol. 2022 Sep 16;12:1008361. doi: 10.3389/fonc.2022.1008361. eCollection 2022. Front Oncol. 2022. PMID: 36185215 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials